These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inspiratory muscle training for children and adolescents with neuromuscular diseases: A systematic review. Human A; Corten L; Jelsma J; Morrow B Neuromuscul Disord; 2017 Jun; 27(6):503-517. PubMed ID: 28462787 [TBL] [Abstract][Full Text] [Related]
4. Clinical trials in chronic neuromuscular diseases: Proceedings of a colloquium at Totts Gap Institute, Bangor, PA, sponsored by the Muscular Dystrophy Association. Wolf S; Lewis NJ Muscle Nerve; 1985; 8(6):451, 454-92. PubMed ID: 16758571 [No Abstract] [Full Text] [Related]
5. [Practices in neuromuscular diseases]. Kuntzer T Rev Med Suisse; 2014 Apr; 10(428):947-8. PubMed ID: 24834614 [No Abstract] [Full Text] [Related]
6. Neuromuscular diseases in children: a practical approach. Brandom BW; Veyckemans F Paediatr Anaesth; 2013 Sep; 23(9):765-9. PubMed ID: 23927523 [No Abstract] [Full Text] [Related]
7. Management of acute neuromuscular disorders. Wijdicks EF Handb Clin Neurol; 2017; 140():229-237. PubMed ID: 28187801 [TBL] [Abstract][Full Text] [Related]
9. Important advances in neuromuscular research in 2019. Bril V Lancet Neurol; 2020 Jan; 19(1):14-16. PubMed ID: 31839239 [No Abstract] [Full Text] [Related]
10. Too much hype, not enough hope: are balanced reporting and proper controls too much to expect from therapeutic studies in animal models of neuromuscular diseases that presage clinical trials in humans? Bretag A Neuromuscul Disord; 2007 Mar; 17(3):203-5. PubMed ID: 17324571 [No Abstract] [Full Text] [Related]
11. Regional and whole-body dual-energy X-ray absorptiometry to guide treatment and monitor disease progression in neuromuscular disease. Skalsky AJ; Han JJ; Abresch RT; McDonald CM Phys Med Rehabil Clin N Am; 2012 Feb; 23(1):67-73, x. PubMed ID: 22239875 [TBL] [Abstract][Full Text] [Related]
12. Neurotrophic factors in neuromuscular disease. Distad BJ; Weiss MD Phys Med Rehabil Clin N Am; 2005 Nov; 16(4):999-1014, x. PubMed ID: 16214056 [No Abstract] [Full Text] [Related]
13. New treatments for neuromuscular disease: optimism and obstacles. Lochmüller H; Griggs RC Neurotherapeutics; 2008 Oct; 5(4):497-8. PubMed ID: 19019299 [No Abstract] [Full Text] [Related]
14. Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials. Carlier PG; Marty B; Scheidegger O; Loureiro de Sousa P; Baudin PY; Snezhko E; Vlodavets D J Neuromuscul Dis; 2016 Mar; 3(1):1-28. PubMed ID: 27854210 [TBL] [Abstract][Full Text] [Related]
15. Workshop on physiotherapy for adults with neuromuscular diseases held at the MRC Centre for Neuromuscular Diseases, Queen Square, London, UK on 28th March 2011. Hiscock A; Dewar L; Ramdharry G Neuromuscul Disord; 2012 Nov; 22(11):1029-31. PubMed ID: 22824637 [No Abstract] [Full Text] [Related]
16. Neuromuscular problems in the ICU. Damian MS; Srinivasan R Curr Opin Neurol; 2017 Oct; 30(5):538-544. PubMed ID: 28700370 [TBL] [Abstract][Full Text] [Related]
17. Clinical Neurophysiology in Neuromuscular Disorders: Old Fashioned or Still Relevant? Müller-Felber W; Vill K Neuropediatrics; 2017 Aug; 48(4):221-225. PubMed ID: 28628940 [No Abstract] [Full Text] [Related]
18. Outcome measures in neuromuscular disease: is the world still flat? Lunn MP; Van den Bergh PY J Peripher Nerv Syst; 2015 Sep; 20(3):255-9. PubMed ID: 26114965 [TBL] [Abstract][Full Text] [Related]
19. Management of cardiac involvement in neuromuscular disorders. Finsterer J; Stöllberger C Dev Med Child Neurol; 2006 Oct; 48(10):863. PubMed ID: 16978470 [No Abstract] [Full Text] [Related]
20. Essence, investigation, and management of "neuropathic" pains: hopes from acknowledgment of chaos. Ochoa JL Muscle Nerve; 1993 Oct; 16(10):997-1008. PubMed ID: 7692293 [No Abstract] [Full Text] [Related] [Next] [New Search]